Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Fresh Tracks Therapeutics Inc V.BBI


Primary Symbol: FRTX

Healthcare Biotechnology
Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.


PINL:FRTX - Post by User

Fresh Tracks Therapeutics Inc > Earnings
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(9)
•••
Comment by kurt73on Mar 08, 2021 6:01pm
242 Views
Post# 32748258

RE:RE:RE:RE:RE:RE:RE:RE:RE:Earnings

RE:RE:RE:RE:RE:RE:RE:RE:RE:Earnings If february flowrates are included in the report its very possible we fly through the $2 mark. Being snoopy with people in the area and it sounds like we are well above 20,000 bbls/day. Hard to completely pinpoint but really interested to see if they adjust upwards volumes going forward
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities